FDA Commissioner: Patient Safety Must Be Prioritized Over Job Creation

Share on Facebook
FDA commissioner Margaret Hamburg, MD, and regulatory officials from Canada and Europe, said they would not back down from strict oversight of quality at food and drug manufacturing companies despite the suffering economy, according to a Philadelphia Inquirer report.

Dr. Hamburg was joined by Paul Glover of Health Canada and Guido Rasi of the European Medicines Agency at the Drug Information Association's 48th annual meeting.

 

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!



The FDA was recently scrutinized by Congressional members who believe the agency has impeded job creation by shutting down plants with quality control problems. Dr. Hamburg stressed quality concerns, such as glass shards and metal fractures in tobacco products, could not be ignored by the FDA and other regulators.

Mr. Glover added a universal reporting mechanism could more quickly alert regulators about adverse events and promote patient safety around the world.

More Articles on Patient Safety:

Congress Passes FDA Safety and Innovation Act With Drug Shortage Provisions

Congressmen Introduce Legislation Designed to Boost Imaging Safety

AHRQ 2011 State Snapshots Spotlight Healthcare Quality, Population Health

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's Infection Control & Clinical Quality

Patient safety tool: AHIMA, AHDI's QA program implementation resource kit

Read Now